
Experience the benefits of taking part in medical research
View ongoing trials >
TrialTech Medical, part of the Scarritt Group Companies portfolio, uses state of the art technology to expand trial awareness, including outreach to underrepresented patient populations.
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-center Trial of MBG-36 for the treatment of migraines in adult patients.
FREEDOM-3 is a Phase 2 trial exploring the safety and clinical activity of FCR001 in patients with a severe form of scleroderma.
Give a breakdown of the trial, disease, medication and anything else related to this trial. This will be a brief explanation that links to the Ongoing Trials page for additional information, as well as the option to sign up for a trial.
Click here for more information
Give a breakdown of the trial, disease, medication and anything else related to this trial. This will be a brief explanation that links to the Ongoing Trials page for additional information, as well as the option to sign up for a trial.
More information u0026gt;: Scarritt Sciences Group Acquires TrialTech Medical
How can we help?